Literature DB >> 15168770

Nonalcoholic steatohepatitis with improved hepatic fibrosis after weight reduction.

Keita Fujikawa1, Kazuyuki Ohata, Takuya Honda, Seiji Miyazoe, Tatsuki Ichikawa, Hiroki Ishikawa, Keisuke Hamasaki, Kazuhiko Nakao, Kan Toriyama, Katsumi Eguchi.   

Abstract

A 65-year-old woman was admitted to our hospital for an investigation of liver dysfunction. She had mild obesity with hyperlipidemia, but no history of alcohol abuse. Other known causes of liver dysfunction, such as viruses, autoimmunity and drug effects, were excluded. The liver histology was consistent with nonalcoholic steatohepatitis (NASH). After diagnosis of NASH, the patient started diet and exercise therapy and, in parallel with weight reduction, her liver function improved. One year after the therapy, a liver biopsy showed that steatosis, necroinflammation and even fibrosis were improved. Hence, here we report a case of NASH in which weight reduction was effective in improving both biochemical and histological findings.

Entities:  

Mesh:

Year:  2004        PMID: 15168770     DOI: 10.2169/internalmedicine.43.289

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  6 in total

1.  Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study.

Authors:  Teruki Miyake; Teru Kumagi; Masashi Hirooka; Shinya Furukawa; Mitsuhito Koizumi; Yoshio Tokumoto; Teruhisa Ueda; Shin Yamamoto; Masanori Abe; Kohichiro Kitai; Yoichi Hiasa; Bunzo Matsuura; Morikazu Onji
Journal:  J Gastroenterol       Date:  2012-08-31       Impact factor: 7.527

Review 2.  Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature.

Authors:  Masafumi Ono; Toshiji Saibara
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

Review 3.  A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease.

Authors:  P Riley; J O'Donohue; M Crook
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

Review 4.  The blind men 'see' the elephant-the many faces of fatty liver disease.

Authors:  Madhusudana Girija Sanal
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

5.  Predictive factors for the development or regression of Fatty liver in Japanese adults.

Authors:  Katsuhisa Omagari; Shun-Ichi Morikawa; Seiko Nagaoka; Yukiko Sadakane; Miki Sato; Mizuho Hamasaki; Shigeko Kato; Jun-Ichi Masuda; Masayuki Osabe; Takehiko Kadota; Keisuke Sera
Journal:  J Clin Biochem Nutr       Date:  2009-06-30       Impact factor: 3.114

6.  A nomogram for estimating the probability of nonalcoholic fatty liver disease in a Chinese population: A retrospective cohort study.

Authors:  Weining Xie; Shengxin Chen
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.